Quantum Biopharma (QNTM) Shares Issued (2019 - 2026)
Quantum Biopharma's (QNTM) quarterly Shares Issued came in at $5.4 million in Q1 2026, up 11658.67% year-on-year from N/an in Q1 2025, and up 12573.59% quarter-over-quarter from -$43257.0 in Q4 2025.
Quantum Biopharma (QNTM) Shares Issued (2019 - 2026) Analysis & Trends
Quantum Biopharma has disclosed Shares Issued across 6 years of filings, most recently posting $5.4 million for Q1 2026.
- Shares Issued for Q1 2026 came in at $5.4 million, up 11658.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.3 million (down 48.66% YoY), and the FY2024 annual result was $10.7 million, up 33473.35% from the prior year.
- Shares Issued came in at $5.4 million for Q1 2026 at Quantum Biopharma, up from -$43257.0 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $7.0 million in Q3 2024 to a low of -$43257.0 in Q4 2025.
- The 4-year median for Shares Issued is $45887.0 (2025), against an average of $1.5 million.
- Across the five-year window, Shares Issued jumped 22067.02% in 2024 and sank 102.91% in 2025, its largest moves.
- Quantum Biopharma's Shares Issued stood at $31783.0 in 2023, then surged by 4573.78% to $1.5 million in 2024, then sank by 102.91% to -$43257.0 in 2025, then jumped by 12573.59% to $5.4 million in 2026.
- The last three Shares Issued figures came in at $5.4 million (Q1 2026), -$43257.0 (Q4 2025), and -$2630.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 5.40 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 27.00 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 26,927.15 |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 163.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.40 Mn |
| Mar 31, 2026 | 5.40 Mn |
| Dec 31, 2025 | -43,257.00 |
| Dec 31, 2025 | -43,257.00 |
| Jun 30, 2025 | -2,630.00 |
| Jun 30, 2025 | -2,630.00 |
| Mar 31, 2025 | 45,887.00 |
| Mar 31, 2025 | 45,887.00 |
| Dec 31, 2024 | 1.49 Mn |
| Dec 31, 2024 | 1.49 Mn |
| Sep 30, 2024 | 7.05 Mn |
| Sep 30, 2024 | 7.05 Mn |
| Jun 30, 2024 | 1.84 Mn |
| Jun 30, 2024 | 1.84 Mn |
| Mar 31, 2024 | 296,437.00 |
| Mar 31, 2024 | 296,437.00 |
| Sep 30, 2023 | 31,783.00 |
| Sep 30, 2023 | 31,783.00 |
| Jun 30, 2023 | -8,646.00 |
| Jun 30, 2023 | -8,646.00 |